OAKLAND COUNTY MICHIGAN'S MEDICAL MAIN STREET OFF TO GREAT START: 5 COMPANIES, $9.2 MILLION IN NEW INVESTMENT AND 240 NEW JOBS

OAKLAND COUNTY MICHIGAN'S MEDICAL MAIN STREET OFF TO GREAT START: 5 COMPANIES, $9.2 MILLION IN NEW INVESTMENT AND 240 NEW JOBS
 
WATERFORD, Mich. - Oakland County Michigan's Medical Main Street has had a great first year.  This initiative to grow the life sciences industry in Southeast Michigan has already produced some great results.  Since it's inception in September 2008, Medical Main Street has attracted the expansion of 5 life sciences companies:
 
Novixus
MicroDose Life Sciences
RG Medical Diagnostics
Oakland Genetics
Oxid Corporation
 
These companies resulted in the creation of 249 new jobs to Oakland County and an investment of over $9 million.  Oakland County Executive L. Brooks Patterson comments, "We are very excited at the progress we've made so far.  Here in Oakland County we have the workforce, we have the cheap real estate and we have some great financial incentives for companies that are looking to locate in our community."  Patterson continues, " We look forward to talking to more life sciences companies as they look to find a good North American location for their company - Oakland County, Michigan is that place."
 
In addition to company attraction, Medical Main Street also looks at helping entrepreneurs commercialize their life sciences technologies, assist local life sciences companies in growing their markets globally, continue to train the workforce for this industry, and working with state government to ensure Michigan is legislatively a top state for life sciences companies to do business in.
 
 About Oakland County Michigan's Medical Main Street:
Oakland County Michigan's Medical Main Street is a unique alliance of world-class hospitals, universities, medical device and BioPharma companies creating a global center of innovation in health care, research and development, education and commercialization in the life sciences industry.  Visit www.MedicalMainStreet.org  to get involved in the medical solutions of the future.

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.